Afjal H. Miah

2.5k citations
18 papers · 710 indexed · h-index 9
Topics
Protein Degradation and Inhibitors (7 papers)Ubiquitin and proteasome pathways (5 papers)Multiple Myeloma Research and Treatments (3 papers)

In The Last Decade

Afjal H. Miah

18 papers receiving 698 citations

Peers

Afjal H. Miah
Comparison fields: 5 of 50
  • Molecular Biology 622
  • Oncology 236
  • Organic Chemistry 135
  • Hematology 121
  • Immunology 35
Replace Nikolai Makukhin with:
Nikolai Makukhin United Kingdom
Michael J. Roy Australia
Joshua D. Hansen United States
Mette Ishoey Denmark
Emanuela Capota United States
Fuming Xu China
Chandraiah Lagisetti United States
Attilla Ting United Kingdom
Nerea Gallastegui Germany
Jason Boggs United States
Afjal H. Miah relative to Nikolai Makukhin United Kingdom Nikolai Makukhin's profile →
Citations per field
00.5×3.5×
Nikolai Makukhin · 1×
Citations per year

Countries citing papers authored by Afjal H. Miah

Since Specialization
Citations

This map shows the geographic impact of Afjal H. Miah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afjal H. Miah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afjal H. Miah more than expected).

Fields of papers citing papers by Afjal H. Miah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afjal H. Miah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afjal H. Miah. The network helps show where Afjal H. Miah may publish in the future.

Co-authorship network of co-authors of Afjal H. Miah

This figure shows the co-authorship network connecting the top 25 collaborators of Afjal H. Miah. A scholar is included among the top collaborators of Afjal H. Miah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afjal H. Miah. Afjal H. Miah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 3
2 5
3 8
4 16
5 21
6 26
7 49
8 6
9 2
10 121
11 8
12 6
13 342
14 7
15 12
16 52
17 7
18 19

About Afjal H. Miah

Afjal H. Miah is a scholar working on Hematology, Oncology and Organic Chemistry, having authored 18 papers that have together received 710 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (121 citations), Molecular Biology (622 citations) and Oncology (236 citations). Afjal H. Miah has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include John D. Harling, Ian E. Smith, Jeffrey L. Gustafson, Kanak Raina, Nicole Darricarrère, Dennis L. Buckley, John Hines, Craig M. Crews, Ian Churcher and Jonathan M. Percy. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026